Senior Director, Global Commercial Leader, Lung Cancer Disease Area Strategy (DAS) and Pipeline

BeiGene continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.

General Description:

BeiGene, a global oncology company, has produced a robust pipeline of New Molecular Entities (NMEs) with potential to change the standard of care across numerous disease areas.  Approximately 10 additional NMEs can be expected from the Discovery organization in 2025, adding to an already comprehensive set of molecules spanning multiple modalities and which are currently in early- and late-stage Clinical Development.  This pipeline maturation has driven BeiGene growth and generated challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly share our passion to fight cancer and our commitment to serve patients wherever they reside.

As the Senior Director, Global Commercial Leader, Lung Cancer Disease Area Strategy (DAS) and Pipeline, you will play a critical leadership role in our newly formed Global Commercial Strategy and Operations team.  You will be responsible for overlaying a commercial perspective that guides our Research and Development efforts in the Lung Cancer disease area, with efforts to help create differentiated Target Product Profiles (TPPs), sizing commercial opportunities, generating insights into patient and physician unmet needs, and guiding investment into the most productive and impactful areas.   You will serve as the Commercial voice on DAS and Early Development Teams (EDTs) helping to ensure a robust evidence package that meets the needs of various Regional stakeholders including Regulatory and Reimbursement bodies around the globe.  This role requires comprehensive knowledge of the Lung Cancer market landscape, a deep understanding of the drug development process, and a keen business acumen.  The role reports to the Vice President, Global Commercial Solid Tumor Franchise Lead.

Essential Functions of the job:

• Create and ensure execution of the insights generation plan that helps inform BeiGene understanding of unmet needs, likely evolution in the standard of care, and key stakeholder requirements to drive adoption of emerging therapies. 
• In partnership with the Business Insights (CBDI) team, ensure a comprehensive understanding of the relevant patient segments, marketplace events, and industry pipeline in Lung Cancer.  Present key updates as needed to Project and Executive teams.
• In close coordination with Early Development Teams and the Disease Area Strategy team, ensure a comprehensive set of TPPs are developed and maintained.  As a best practice, the TPPs will be based upon deep customer and competitive insights which guide the development of differentiated assets. 
• In partnership with Portfolio Strategy & Valuation (PS&V) colleagues, advance efforts to quantify the commercial potential of target patient populations as identified within the TPPs, and ensure full evidence requirements to secure global reimbursement are captured within the TPP and asset development plans.
• Represent ONE commercial voice to Early Development Teams (EDTs), including the priority PanKRASi and PRMT5 programs.  Coordinate with other commercial stakeholders to ensure an integrated, global commercial perspective is included in early asset development decisions.
• Help relevant functional partners maintain pipeline valuation metrics for the Lung Cancer portfolio, ensuring any investment decisions are supported by robust commercial assessments and balance BeiGene priorities on risk / return considerations, and speed to the marketplace.
• Collaborate with cross-regional, and cross-functional team members to shape disease area strategies for multiple indications.
• As required, guide commercial decisions regarding early asset positioning, messaging, and branding considerations prior to the formation of Global Product Teams (GPTs).
• In close coordination with cross-functional team members such as Medical Affairs and Corporate Affairs, identify partnership opportunities with Lung Cancer patient organizations and define/execute tactics aligned to the shared agenda of disease education and improving access to efficacious therapies around the globe.
• Lead cross-functional collaboration to ensure alignment of global commercial strategies within the DAS, including members from R&D, medical affairs, market access and major market organizations.
• Partner with Tech Ops to address any capacity planning considerations.
• Maintain strong relationships with both internal colleagu